ELV
Elevance Health, Inc.
Stock
$386.43+4.76 (+1.25%)Close Oct 2, 2026
- Operating income, 2025
- $7.2B
- YoY, 2025
- −8.4%
- 5-year CAGR
- +2.5%
- 10-year CAGR
- +4.2%
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | $7.2B | −8.4% |
| 2024 | $7.9B | −7.5% |
| 2023 | $8.5B | +2.6% |
| 2022 | $8.3B | +9.6% |
| 2021 | $7.6B | +18.9% |
| 2020 | $6.4B | +6.0% |
| 2019 | $6.0B | +10.6% |
| 2018 | $5.4B | +30.0% |
| 2017 | $4.2B | −13.0% |
| 2016 | $4.8B | +1.0% |
| 2015 | $4.8B | +7.6% |
| 2014 | $4.4B | +10.4% |
| 2013 | $4.0B | +10.5% |
| 2012 | $3.6B | −4.3% |
| 2011 | $3.8B | −7.2% |
| 2010 | $4.1B | −2.4% |
| 2009 | $4.2B | −3.9% |
| 2008 | $4.3B | — |